The Association between the Triglyceride to High-density Lipoprotein Cholesterol Ratio and Low-density Lipoprotein Subclasses

被引:11
|
作者
Moriyama, Kengo [1 ]
机构
[1] Tokai Univ, Sch Med, Dept Clin Hlth Sci, Hiratsuka, Kanagawa, Japan
关键词
triglyceride to high-density lipoprotein cholesterol ratio; malondialdehyde-modified low-density lipoprotein; small dense low-density lipoprotein cholesterol; MALONDIALDEHYDE-MODIFIED LDL; INSULIN-RESISTANCE; PLASMA; INDIVIDUALS; POPULATION; GLUCOSE; RISK;
D O I
10.2169/internalmedicine.4954-20
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective The triglyceride (TG)/high-density lipoprotein cholesterol (HDL-C) ratio is related to insulin resistance (IR). However, information about whether or not the TG/HDL-C ratio is associated with low-density lipoprotein (LDL) subclasses in the Japanese population is limited. Methods In total, 1,068 Japanese subjects who underwent an annual health examination and who were not taking medications were recruited. The association between the TG/HDL-C ratio and LDL subclasses was investigated using correlation, multiple regression, and receiver operating characteristic analyses. Results A correlation analysis revealed that both malondialdehyde-modified low-density lipoprotein (MDALDL) and small dense low-density lipoprotein cholesterol (sdLDL-C) were positively associated with the TG/ HDL-C ratio. Furthermore, a multiple linear regression analysis revealed that the TG/HDL-C ratio was positively associated with MDA-LDL and sdLDL-C in both men and women. The multiple logistic regression analysis also revealed that the TG/HDL-C ratio was positively associated with the upper tertile of MDA-LDL and sdLDL-C in men and women. The LDL-C levels increased with the increasing TG/HDL-C ratio. The MDA-LDL and sdLDL-C are known to be positively associated with LDL-C. However, within the same LDL-C range, both MDA-LDL and sdLDL-C levels increased with the TG/HDL-C ratio, except for MDALDL levels in the LDL-C <112 mg/dL group in women. These results further supported the notion that the TG/HDL-C ratio was positively associated with the MDA-LDL and sdl.DL-C levels, especially in the higher LDL-C range, in both men and women. The optimal cut-off points of the TG/HDL-C ratio for the upper tertile of MDA-LDL and sdI.DL-C were 1.85 and 2.03 in men and 0.88 and 1.30 in women, respectively. Conclusion The TG/HDL-C ratio is positively associated with MDA-LDL and sdLDL-C in Japanese subjects. The relationship was particularly notable in subjects with high LDL-C levels.
引用
收藏
页码:2661 / 2669
页数:9
相关论文
共 50 条
  • [1] Relationship between total cholesterol/high-density lipoprotein cholesterol ratio, triglyceride/high-density lipoprotein cholesterol ratio, and high-density lipoprotein subclasses
    Jia, Lianqun
    Long, Shiyin
    Fu, Mingde
    Yan, Bingyu
    Tian, Ying
    Xu, Yanhua
    Gou, Lantu
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2006, 55 (09): : 1141 - 1148
  • [2] Accuracy of the triglyceride to high-density lipoprotein cholesterol ratio for prediction of the low-density lipoprotein phenotype B
    Hanak, V
    Munoz, J
    Teague, J
    Stanley, A
    Bittner, V
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2004, 94 (02): : 219 - 222
  • [3] Association between the severity of obstructive sleep apnea and the ratio of low-density lipoprotein cholesterol to high-density lipoprotein cholesterol
    Kawano, Yoshiyuki
    Tamura, Akira
    Kadota, Junichi
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2012, 61 (02): : 186 - 192
  • [4] Statins, high-density lipoprotein, and the low-density lipoprotein/high-density lipoprotein ratio
    Silva, JM
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2000, 86 (05): : 593 - 594
  • [5] Association of the Low-density Lipoprotein Cholesterol/High-density Lipoprotein Cholesterol Ratio with Glecaprevir-pibrentasvir Treatment
    Akutsu, Noriyuki
    Sasaki, Shigeru
    Matsui, Takeshi
    Akashi, Hirofumi
    Yonezawa, Kazuhiko
    Ishigami, Keisuke
    Tsujisaki, Masayuki
    Isshiki, Hiroyuki
    Yawata, Atsushi
    Yamaoka, Satoshi
    Ban, Toshihiro
    Adachi, Takeya
    Nakahara, Seiya
    Takagi, Hideyasu
    Nakachi, Kohei
    Tanaka, Katsunori
    Hirano, Takehiro
    Yamamoto, Itaru
    Kaneto, Hiroyuki
    Wagatsuma, Kohei
    Numata, Yasunao
    Nakase, Hiroshi
    [J]. INTERNAL MEDICINE, 2021, 60 (21) : 3369 - 3376
  • [6] Association of the low-density lipoprotein cholesterol/high-density lipoprotein cholesterol ratio and concentrations of plasma lipids with high-density lipoprotein subclass distribution in the Chinese population
    Li Tian
    Yinghui Liu
    Yang Qin
    Shiyin Long
    Yanhua Xu
    Mingde Fu
    [J]. Lipids in Health and Disease, 9
  • [7] Association of the low-density lipoprotein cholesterol/high-density lipoprotein cholesterol ratio and concentrations of plasma lipids with high-density lipoprotein subclass distribution in the Chinese population
    Tian, Li
    Liu, Yinghui
    Qin, Yang
    Long, Shiyin
    Xu, Yanhua
    Fu, Mingde
    [J]. LIPIDS IN HEALTH AND DISEASE, 2010, 9
  • [8] Distribution of Low-Density Lipoprotein and High-Density Lipoprotein Subclasses in Patients With Sarcoidosis
    Vekic, Jelena
    Zeljkovic, Aleksandra
    Jelic-Ivanovic, Zorana
    Spasojevic-Kalimanovska, Vesna
    Spasic, Slavica
    Videnovic-Ivanov, Jelica
    Ivanisevic, Jasmina
    Vucinic-Mihailovic, Violeta
    Gojkovic, Tamara
    [J]. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2013, 137 (12) : 1780 - 1787
  • [9] The Triglyceride/High-Density Lipoprotein Cholesterol Ratio, the Small Dense Low-Density Lipoprotein Phenotype, and Ischemic Heart Disease Risk
    St-Pierre, Annie C.
    Cantin, Bernard
    Dagenais, Gilles R.
    Mauriege, Pascale
    Despres, Jean-Pierre
    Lamarche, Benoit
    [J]. METABOLIC SYNDROME AND RELATED DISORDERS, 2004, 2 (01) : 57 - 64
  • [10] Association of the Low-Density Lipoprotein Cholesterol/High-Density Lipoprotein Cholesterol Ratio and Body Mass Index with Coronary Plaque Regression
    Tani, Shigemasa
    Matsumoto, Michiaki
    Nakamura, Yasutaka
    Nagao, Ken
    Hirayama, Atsushi
    [J]. AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2012, 12 (04) : 279 - 286